| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/17/2001 | CN1279964A Method for removing farm chemical ingredients from ginseng extract |
| 01/17/2001 | CN1279953A Application of seeweed polyose sulphate |
| 01/17/2001 | CN1279952A Clindamycin phosphate preparation for transfusion |
| 01/17/2001 | CN1279951A Use of ecdysterone in preparing medicine for angiocardiopathy |
| 01/17/2001 | CN1279950A Sigma-receptor acting medicine with triterpene compound structure |
| 01/17/2001 | CN1279949A Compound hypoglycemic nutrient |
| 01/17/2001 | CN1279948A Hypoglycemic for type II diabetes |
| 01/17/2001 | CN1279947A Eye preparation of zinc norfloxacin |
| 01/17/2001 | CN1279946A Berberine hydrochloride suppository and its producing method |
| 01/17/2001 | CN1279945A Gastric floating slow-releasing tinidazole capsule and its preparing method |
| 01/17/2001 | CN1279944A Effervescent tablets for curing vaginitis and its preparing method |
| 01/17/2001 | CN1279942A Medicinal aerosol for curing respiratory system disease |
| 01/17/2001 | CN1279939A Local use cosmetic compositions containing benzaldoximes compounds |
| 01/17/2001 | CN1060782C Preparation and application of sargassum polysaccharide complex |
| 01/17/2001 | CN1060781C Phosphonomonoester nucleic acids, process for treir preparation, and their use |
| 01/17/2001 | CN1060778C Cephalosporin derivatives |
| 01/17/2001 | CN1060776C Procell for manufactare of imidazo benzodiazepine derivatives |
| 01/17/2001 | CN1060775C Fused troane-derivatives as neurotransmitter reuptake inhibitors |
| 01/17/2001 | CN1060774C Process for preparation of enantionerically pure imidazolyl compounds |
| 01/17/2001 | CN1060773C Naphthamide derivatives of 3-beta-amino azabicyclo octane or nonane as heuroleptic agents |
| 01/17/2001 | CN1060772C New Indole, Indazole and benzisoxazole compounds, their process of preparation and pharmaceutical compositions which contain them |
| 01/17/2001 | CN1060770C Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
| 01/17/2001 | CN1060768C Pyrazoles and pyrazolopyrimidines |
| 01/17/2001 | CN1060767C Substituted benzene sulfonyl usea and benzene sulfonyl thiourea and mfg, method and use as raw material for medicine and medicine containing them |
| 01/17/2001 | CN1060764C Ortho-substituted benzoylguanidine, preparation method, use as medicine or diagnostic reagent and medicine containing them |
| 01/17/2001 | CN1060763C Urea-substituted benzoylguanidines, process for their preparation, and use and pharmaceutical containing them |
| 01/17/2001 | CN1060761C New aryl (alkyl) propylamides, process for preparing them and pharmaceutical compositions containing them |
| 01/17/2001 | CN1060679C Use of combination of angiotensin-converting enzyme inhibitor and calcium antagonist for treatment of proteinuria |
| 01/17/2001 | CN1060675C Medicine for treating epilepsy |
| 01/17/2001 | CN1060652C Rhinitis liniment and its preparation |
| 01/17/2001 | CN1060649C Medicine for curing vitiligo |
| 01/17/2001 | CN1060646C Injection solution for giving up addiction of drug addict and its preparing method |
| 01/16/2001 | USRE37020 Administering an elderly patient a protein source, a lipid source includes triglycerides and a carbohydrate source includes a source of dietary fiber, preferably, the protein source includes atleast 18% of the total calories as |
| 01/16/2001 | US6175035 Method of producing betulinic acid |
| 01/16/2001 | US6175023 Synthesis of water soluble 9-dihydro-paclitaxel derivatives from 9-dihydro-13-acetylbaccatin III |
| 01/16/2001 | US6175021 Human non-pancreatic secretory phospholipase a2 (spla2); inhibits release of arachidonic acid to treat septic shock; ((3-(2-amino-1,2-dioxoethyl)-2-methyl-1-(phenylmethyl)-1h-indol-4 -yl)oxylacetic acid, for example |
| 01/16/2001 | US6175014 Process for the preparation of lactam derivatives |
| 01/16/2001 | US6175013 1-(2-methoxybenzyl)-2-((4-phenyl-1-piperazinyl)methyl)-4-(1h -indol-3-ylmethyl)-2-imidazoline, for example; adminstering to treat anxiety, depression, psychosis, and schizophrenia |
| 01/16/2001 | US6174994 7TM receptor (H2CAA71) |
| 01/16/2001 | US6174925 Reducing insulin resistance in humans in whom impaired glucose tolerance or non-insulin dependent diabetes mellitus have not presented but in whom there is increased risk of developing such conditions by administering sibutramine analogue |
| 01/16/2001 | US6174924 Treating nerve cell death comprising administering to a subject exhibiting symptoms of nerve cell death or susceptible to nerve cell death a substituted guanidine compound |
| 01/16/2001 | US6174923 Administering ethynyl alanine amino diol compound for treating hypertension |
| 01/16/2001 | US6174921 Antitumor compositions and methods of treatment |
| 01/16/2001 | US6174917 Treatment of liver disease such as cirrhosis of liver, toxic and medicamentary liver damage, liver-parenchymic disorder or hepatitis, by oral administrering low dose of a vasodilating agent which selectively increases supply of oxygenated blood |
| 01/16/2001 | US6174914 Method of inhibiting cytokine release from human ocular cells |
| 01/16/2001 | US6174913 Treating tumor by administering compounds e.g.:2-acetyl-naphtho(2,3-b)thiophene-4,9-dione; 2,7-diacetyl-naphtho(2,3-b)thiophene-4,9-dione |
| 01/16/2001 | US6174910 Treating pathological symptoms of vascular proliferation disorders which can be reduced or inhibited by apoptosis, by administering at.sub.1(angiotensin) receptor antagonist compound such as valsartan, irbesartan, losatran etc. |
| 01/16/2001 | US6174909 For treating analgesia, psychosis, convulsions, epilepsy, anxiety, muscular and movement disorders, spastic disorders or symptoms of huntington's or parkinsons disease |
| 01/16/2001 | US6174908 Treating disease, condition, or disorder which responds to inhibition of potassium channel function by administering thiazolidone or metathiazonone compound, its salt, amide, ester, complex, chelate, hydrate, stereoisomer, metabolite |
| 01/16/2001 | US6174906 Endothelin receptor antagonists |
| 01/16/2001 | US6174904 Treating glycometabolism disorders in mammals by administering therapeutically effective amount of an insulin sensitivity enhancer in combination with an .alpha.-glucosidase inhibitor |
| 01/16/2001 | US6174903 Imidazolidin-4-one derivatives useful as anticancer agents |
| 01/16/2001 | US6174902 Treating ulcers by administering to human therapeutically effective amount of optically pure r(+)isomer of rabeprazole, or a pharmaceutically acceptable salt |
| 01/16/2001 | US6174899 Orally administered analgesic composition comprising myfadol |
| 01/16/2001 | US6174898 Method of treating filariae |
| 01/16/2001 | US6174897 For treatment of brain dissorders such as dementia, depression, myotonic dystrophy, alcoholism and other addiction diseases, sleep disturbances and bronchial asthma, presenile alzheimer's disease |
| 01/16/2001 | US6174896 Quinuclidine derivatives and medicinal composition thereof |
| 01/16/2001 | US6174895 1-aryl-3-arylmethyl-1,8-naphthyridin-4(1H)-ones |
| 01/16/2001 | US6174892 Method of treating acne with 5-α reductase inhibitors |
| 01/16/2001 | US6174891 Antipruritic agent |
| 01/16/2001 | US6174890 A synergistic biological, neurometabolic and celltrophic composition comprising antioxidative and -catabolic stress (methionine),-anabolic drugs, vasodilative and normo-lipidemic drugs (nicotinic acid), energoactive and antitoxic |
| 01/16/2001 | US6174889 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/16/2001 | US6174888 Potent purine nucleoside phosphorylase inhibitors; inhibitors of t-cell formation, i.e., immunosuppressants; transplant rejection; autoimmune diseases, e.g., rheumatoid diseases, psoriasis, dermatitis, crohn's disease, uveitis; |
| 01/16/2001 | US6174887 Amide compounds and use of the same |
| 01/16/2001 | US6174886 Antipsychotic use of triazolo-pyridazine derivatives |
| 01/16/2001 | US6174884 1,5-dihydro-pyrazolo[34-D]-pyrimidinone derivatives |
| 01/16/2001 | US6174883 3-substituted-2-oxindoles derivatives |
| 01/16/2001 | US6174882 Treating psychosis, acute mania, schizophrenia, excessive agression, substance abuse and fungal dermatitis; bipolar, autistism, tic, functional bowel and attention deficit hyperactivity disorders, anxiolytic agents; antidepressants |
| 01/16/2001 | US6174881 Hydroxymethylimidazodiazepines and their esters |
| 01/16/2001 | US6174880 Method for treatment of painful fibromuscular disorder |
| 01/16/2001 | US6174878 Topical use of kappa opioid agonists to treat otic pain |
| 01/16/2001 | US6174876 Use of boswellic acid for treating brain tumors |
| 01/16/2001 | US6174875 Benzoquinoid ansamycins for the treatment of cardiac arrest and stroke |
| 01/16/2001 | US6174874 Phosphonic acids derivatives as inhibitors of protein tyrosine phosphate 1B (PTP-1B) |
| 01/16/2001 | US6174873 Oral administration of adenosine analogs |
| 01/16/2001 | US6174869 Method for enhancing neurone survival and agents useful for same |
| 01/16/2001 | US6174868 Compositions and methods for treatment of hepatitis C virus-associated diseases |
| 01/16/2001 | US6174867 Inhibition of the binding of a toxin or organism to its corresponding cell surface receptor; e.g., heat-labile enterotoxin or cholera toxin or enterovirulent organisms; bactericides, viricides, fungicides |
| 01/16/2001 | US6174865 Method of treating hypertriglyceridemia with an erythromycin compound |
| 01/16/2001 | US6174864 Methods for the prevention or treatment of inflammatory bowel diseases |
| 01/16/2001 | US6174863 Carbohydrate derivatives |
| 01/16/2001 | US6174855 Pharmaceutical compositions comprising thrombin inhibitors and their use in the control of wound healing processes |
| 01/16/2001 | US6174714 Lyss |
| 01/16/2001 | US6174687 Methods of identifying lung homing molecules using membrane dipeptidase |
| 01/16/2001 | US6174560 Substance for lowering high cholesterol level in serum and methods for preparing and using the same |
| 01/16/2001 | US6174548 Pharmaceutical composition of omeprazole for oral administration which consists essentially of a tabletted core and coating layer |
| 01/16/2001 | US6174543 Antidiabetic external skin application composition |
| 01/16/2001 | US6174541 Promoting the healing of a tissue wound comprising delivering a therapeutically effective dosage of indole-3-acetic-acid or its derivatives |
| 01/16/2001 | US6174539 Localized use of nitric oxide adducts to prevent internal tissue damage |
| 01/16/2001 | US6174534 Mixture containing fatty acid, ester of polyalkylene ether, hydrogenated palm oil and polyoxyethylenated hydrogenated palm kernel oil, fatty ester, glycerol, fatty alcohol and water |
| 01/16/2001 | US6174531 Methods of preparation of bioginkgo |
| 01/16/2001 | US6174524 Gelling ophthalmic compositions containing xanthan gum |
| 01/16/2001 | CA2314539A1 Use of 4,6-dimethoxy-indole 2-carboxylic acid or its derivatives for the treatment of seborrhoea |
| 01/16/2001 | CA2314008A1 2-benzimidazolylamine compounds as orl1-receptor agonists |
| 01/16/2001 | CA2223404C Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt |
| 01/16/2001 | CA2204355C Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/16/2001 | CA2198099C Use of tasteless, hydrolysed collagen and agent containing the same |
| 01/16/2001 | CA2189916C A new regime for paclitaxel in kaposi's sarcoma patients |
| 01/16/2001 | CA2150234E Combination of atovaquone with proguanil for the treatment of protozoal infections |
| 01/16/2001 | CA2140345C Anti-inflammatory compounds for ophthalmic use |